FARALLON CAPITAL MANAGEMENT LLC - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 111 filers reported holding KRYSTAL BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$232,000
-95.5%
2,000
-97.3%
0.00%
-95.2%
Q2 2021$5,100,000
-89.4%
75,000
-88.0%
0.02%
-91.2%
Q1 2021$48,150,000
+52.9%
625,000
+19.0%
0.24%
+26.5%
Q4 2020$31,500,000
+54.0%
525,000
+10.5%
0.19%
+34.0%
Q3 2020$20,449,000
+9.7%
475,000
+5.6%
0.14%
-5.4%
Q2 2020$18,639,000
+72.4%
450,000
+80.0%
0.15%
+60.2%
Q1 2020$10,810,000250,0000.09%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q4 2020
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 895,000$68,951,0005.53%
S Squared Technology, LLC 85,215$6,565,0003.10%
First Light Asset Management, LLC 491,511$37,866,0002.51%
Soleus Capital Management, L.P. 166,844$12,854,0002.32%
Redmile Group, LLC 2,060,132$158,713,0002.24%
Nicholas Investment Partners, LP 304,689$23,473,0001.64%
HighMark Wealth Management LLC 17,192$1,324,0001.06%
DSAM Partners (London) Ltd 70,274$5,414,0001.00%
Artal Group S.A. 500,000$38,520,0000.68%
Hood River Capital Management LLC 237,882$18,326,0000.59%
View complete list of KRYSTAL BIOTECH INC shareholders